Personalizing Selection of Inhaled Delivery Systems in COPD
It can be challenging for healthcare professionals (HCPs) to prescribe inhaled therapy for patients with chronic obstructive pulmonary disease (COPD) because of the multiple individual and combinations of inhaled medications available in numerous delivery systems.
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Progress in the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease
Pulmonary hypertension, frequently complicating the course of patients with fibrotic interstitial lung disease, is associated with significantly increased morbidity and mortality.
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Impact of Global Climate Change on Pulmonary Health: Susceptible and Vulnerable Populations
As fossil fuel combustion continues to power the global economy, the rate of climate change is accelerating, causing severe respiratory health impacts and large disparities in the degree of human suffering.
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Linking Acute Physiology to Outcomes in the ICU: Challenges and Solutions for Research
ICU clinicians rely on bedside physiological measurements to inform many routine clinical decisions.
Category
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Evolving Management Practices for Early Sepsis-induced Hypoperfusion: A Narrative Review
Sepsis causes significant morbidity and mortality worldwide. Resuscitation is a cornerstone of management.
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Summary for Clinicians: Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
Evidence-based guidelines for the management of idiopathic pulmonary fibrosis (IPF) were updated in 2022 in a multidisciplinary discussion (MDD) by a panel of experts appointed by the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoraci
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Module 2: Relative Risk Assessment: Impact of RSV in the Adult Population
Respiratory syncytial viru
Category
Format
Credits
  • 0.75 ABIM MOC
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Participation
Module 1: Occurrence and Disease Course of RSV Illness in Adults
Respiratory syncytial viru
Category
Format
Credits
  • 1.00 ABIM MOC
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation

Pages